Last deal

$6.72M
Local Amount - EUR 6.2M

Amount

Series A

Stage

25.01.2024

Date

3

all rounds

$9.05M

Total amount

date founded

Financing round

General

About Company
G.ST Antivirals is a company that develops antiviral therapies using an innovative approach to starve viruses within the host cell.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2019

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Founded in 2019 as a spin-off of the Medical University of Vienna, G.ST Antivirals focuses on developing antiviral drugs that interrupt the nutrient supply to viral elements, leading to impaired replication and ultimately helping to treat patients with viral diseases. By exploiting the viral dependency on the host cell metabolism, the company designs specific interventions to counteract viral nutrient supply, resulting in intracellular starvation of the virus.
Contacts

Contact Email

Phone number

Social url

Legal Names

Legal name

G.ST Antivirals GmbH
Similar Companies
1000
KP Biosciences

KP Biosciences

KP Biosciences develops broad-spectrum antiviral treatments for infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Orem, UT, USA
CellVir

CellVir

CellVir is a company that develops anti-retroviral treatments specifically focused on HIV-1.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Évry, 91000 Évry-Courcouronnes, France

total rounds

1

total raised

$387K

AMB Advanced Therapeutics

AMB Advanced Therapeutics enhances antibiotics to treat resistant infections.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care
Indaptus Therapeutics

Indaptus Therapeutics

Indaptus Therapeutics develops a platform that activates both innate and adaptive cellular anti-tumor pathways.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

2

total raised

$33M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$9.05M

Money Raised

Their latest funding was raised on 25.01.2024. Their latest investor Lansdowne Partners. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
25.01.2024
2
$6.72M
Local Amount - EUR 6.2M
03.11.2021
$2.32M
Local Amount - EUR 2M
08.05.2020
1
IST cube

IST cube

ITS Cube is a venture capital firm that invests in deep tech startups and academic spin-offs.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Klosterneuburg, Austria

count Of Investments

25
IST cube

IST cube

ITS Cube is a venture capital firm that invests in deep tech startups and academic spin-offs.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Klosterneuburg, Austria

count Of Investments

25
Co-Investors
Investors
3
2

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series A
Yes
Series A
Lansdowne Partners

Lansdowne Partners

Lansdowne Partners is an alternative investment management firm that specializes in equity portfolios.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Funding Platform, Finance

Location

London, UK

count Of Investments

32

count Of Exists

3
IST cube

IST cube

ITS Cube is a venture capital firm that invests in deep tech startups and academic spin-offs.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Klosterneuburg, Austria

count Of Investments

25
IST cube

IST cube

ITS Cube is a venture capital firm that invests in deep tech startups and academic spin-offs.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Klosterneuburg, Austria

count Of Investments

25

Alexander Schwartz

Dr. Alexander Schwartz serves as a Managing Partner at IST Cube. He also serves as a Board Member at Valanx Biotech, Ribbon Biolabs, and VitreaLab. He serves as an Advisory Board Member at West Asia Investment Partners. He is a managing partner and strategy advisor at ARACON Consulting, and has over 15 years of strategy consulting experience, leading projects in Europe, the United States, and the Middle East. Previously, he worked at the Strategy Practice, Chemicals Practice, and Climate Change practice at McKinsey & Company for eight years. He has been the president of the Harvard Club of Austria since 2013. He holds a PhD in Organic Chemistry from the University of Vienna and was a postdoctoral fellow at Harvard University, as well as a visiting researcher at ETH Zurich. He is currently a research scholar at the International Institute for Applied Systems Analysis (IIASA).

current job

IST cube
IST cube

People

Employee Profiles
2
Guido Gualdoni

Guido Gualdoni

CEO I Co-Founder

Johannes Stöckl

Johannes Stöckl

Co-founder

Activity

Recent News
0